Beranda › Kanker Metastatik › Distrik Columbia › Washington
Uji klinis Kanker Metastatik di Washington, DC
43 studi untuk Kanker Metastatik mencari peserta di lokasi sekitar Washington (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Menerima pesertaFase 2
- Walter Reed National Military Medical Center, Bethesda · 7 mi jauhnya
- National Institutes of Health Clinical Center, Bethesda · 7 mi jauhnya
The Role of 68-Gallium-DOTATATE-PET/CT in the Imaging of Metastatic Thyroid Cancer
Menerima pesertaFase 2
- National Institutes of Health Clinical Center, Bethesda · 7 mi jauhnya
A Study of ASP3082 in Adults With Advanced Solid Tumors
Menerima pesertaFase 1
- Georgetown University Hospital, Washington D.C.
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
Menerima pesertaFase 2/3
- Georgetown University, Washington D.C.
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
Menerima pesertaFase 1
- Johns Hopkins Sibley Memorial Hospital, Washington D.C.
ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
Menerima pesertaFase 2
- The George Washington Medical facility Associates, Washington D.C.
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
Menerima pesertaFase 2/3
- Georgetown University Medical Center - Department of Pharmacy, Oncology Pharmacy, Washington D.C.
- Georgetown University Medical Center, Washington D.C.
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Menerima pesertaFase 3
- Maryland Oncology Hematology, P.A., Silver Spring · 7 mi jauhnya
- Maryland Oncology Hematology, P.A., Bethesda · 7 mi jauhnya
- Maryland Oncology Hematology, P.A., Largo · 11 mi jauhnya
A Study of Zidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1)
Menerima pesertaFase 1/2
- Georgetown University Medical Center, Washington D.C.
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Menerima pesertaFase 3
- MedStar Washington Hospital Center, Washington D.C.
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Menerima pesertaFase 3
- MedStar Washington Hospital Center, Washington D.C.
- American Oncology Partners, PA, Bethesda · 7 mi jauhnya
A Clinical Study of Ifinatamab Deruxtecan Based Treatment Combinations or as Monotherapy to Treat Metastatic Castrate Resistant Prostate Cancer (mCRPC) (MK-2400-01A/IDeate-Prostate02)
Menerima pesertaFase 1/2
- MedStar Georgetown Cancer Institute at MedStar Washington Hospital Center ( Site 0026), Washington D.C.
Testing How the Body Responds to the Drug CX-5461 (Pidnarulex) in Patients With Metastatic Solid Cancers
Menerima pesertaFase 1
- National Cancer Institute Developmental Therapeutics Clinic, Bethesda · 7 mi jauhnya
CR-001 in Adult Participants With Locally Advanced or Metastatic Solid Tumors
Menerima pesertaFase 1/2
- Clinical Study Site, Washington D.C.
The Use of 124-I-PET/CT Whole Body and Lesional Dosimetry in Differentiated Thyroid Cancer
Menerima pesertaFase 2
- National Institutes of Health Clinical Center, Bethesda · 7 mi jauhnya
Durvalumab in Combination With Chemotherapy in Treating Patients With Advanced Solid Tumors, DURVA+ Trial
Menerima pesertaFase 2
- National Cancer Institute Developmental Therapeutics Clinic, Bethesda · 7 mi jauhnya
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Menerima pesertaFase 3
- Sibley Memorial Hospital, Washington D.C.
AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
Menerima pesertaFase 1/2
- Avenzo Therapeutics Recruiting Site, Washington D.C.
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
Menerima pesertaFase 3
- The Center for Cancer and Blood Disorders a division of American Oncology Partners, P.A., Bethesda · 7 mi jauhnya
T Cell Receptor Immunotherapy for Patients With Metastatic Non-Small Cell Lung Cancer
Menerima pesertaFase 2
- National Institutes of Health Clinical Center, Bethesda · 7 mi jauhnya
Testing the Combination of Two Anti-cancer Drugs, Peposertib (M3814) and Tuvusertib (M1774) for Advanced Solid Tumors
Menerima pesertaFase 1
- National Cancer Institute Developmental Therapeutics Clinic, Bethesda · 7 mi jauhnya
A Study of Novel Study Interventions and Combinations in Participants With Colorectal Cancer
Menerima pesertaFase 2
- Research Site, Washington D.C.
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Menerima pesertaFase 1/2
- Johns Hopkins University, Sibley Memorial Hospital, Washington D.C.
Testing How the Body Responds to the Drug CBX-12 in Patients With Advanced Solid Cancers
Menerima pesertaFase 1
- National Cancer Institute Developmental Therapeutics Clinic, Bethesda · 7 mi jauhnya
Studying the Safety and Determining the Optimal Dose of Novobiocin in Patients With Tumors That Have Alterations in DNA Repair Genes
Menerima pesertaFase 1
- National Cancer Institute Developmental Therapeutics Clinic, Bethesda · 7 mi jauhnya
Testing the Combination of the Anti-Cancer Drugs Temozolomide and M1774 to Evaluate Their Safety and Effectiveness
Menerima pesertaFase 1/2
- National Cancer Institute Developmental Therapeutics Clinic, Bethesda · 7 mi jauhnya
Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
Menerima pesertaFase 3
- Research Site, Washington D.C.
- Research Site, Silver Spring · 7 mi jauhnya
Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors
Menerima pesertaFase 1/2
- George Washington University, Washington D.C.
(Peak) A Phase 3 Randomized Trial of CGT9486+Sunitinib vs. Sunitinib in Subjects With Gastrointestinal Stromal Tumors
Menerima pesertaFase 3
- MedStar Washington Hospital Center, Washington D.C.
E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers
Menerima pesertaFase 2
- National Institutes of Health Clinical Center, Bethesda · 7 mi jauhnya
A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)
Menerima pesertaFase 1/2
- Georgetown University Medical Center, Washington D.C.
Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)
Menerima pesertaFase 3
- American Oncology Partners, P.A., Bethesda · 7 mi jauhnya
Studying TAK-243 in Patients With Advanced Cancer
Menerima pesertaFase 1
- National Cancer Institute Developmental Therapeutics Clinic, Bethesda · 7 mi jauhnya
Safety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma.
Menerima pesertaFase 2/3
- The Center for Cancer and Blood Disorders, Bethesda · 7 mi jauhnya
Cancer Experience Registry (CER) for Cancer Patients and Caregivers
Menerima pesertaStudi observasionalSukarelawan sehat diterima
- Cancer Support Community Research & Training Institute, Washington D.C.
A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma
Menerima pesertaFase 3
- The George Washington University, Washington D.C.
Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer
Menerima pesertaFase 2/3
- Washington DC VA Medical Center, Washington, DC, Washington D.C.
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
Menerima pesertaFase 2/3
- Georgetown University Medical Center, Washington D.C.
Phase I Study of Tolododekin Alfa (ANK-101) in Advanced Solid Tumors
Menerima pesertaFase 1
- National Cancer Institute, Bethesda · 7 mi jauhnya
A Study of NVL-330 in Patients With Advanced or Metastatic HER2-altered NSCLC (HEROEX-1)
Menerima pesertaFase 1
- Georgetown University Medical Center, Washington D.C.
- Sibley Memorial Hospital, Washington D.C.
Evaluation of RBS2418 in Subjects With Advanced, Metastatic Solid Tumors
Menerima pesertaFase 1
- American Oncology Partners of Maryland, Bethesda · 7 mi jauhnya
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
Menerima pesertaFase 1/2
- The George Washington University Cancer Center (site 212), Washington D.C.
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Menerima pesertaStudi observasional
- Massive Bio SYNERGY-AI site, Silver Spring · 7 mi jauhnya
- Massive Bio SYNERGY-AI site, Bethesda · 7 mi jauhnya
Uji klinis Kanker Metastatik di kota lain
- Houston, TX104 studi
- New York City, NY93 studi
- Nashville, TN70 studi
- Boston, MA63 studi
- Los Angeles, CA57 studi
- St. Louis, MO54 studi
- Arlington, VA53 studi
- Philadelphia, PA46 studi
- Chicago, IL45 studi
- San Antonio, TX44 studi
- Dallas, TX42 studi
- Seattle, WA39 studi
Studi lain di Washington
- Kanker (semua jenis)58 studi
- Kanker Paru Non-Sel Kecil55 studi
- Kanker Payudara46 studi
- Kanker Paru41 studi
- Kanker Prostat38 studi
- Obesitas33 studi
- Kanker Kolorektal29 studi
- Penyakit Kardiovaskular28 studi
- Kanker Kandung Kemih26 studi
- Leukemia Mieloid Akut24 studi
- Kanker Ovarium23 studi
- Limfoma23 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.